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Introduction
Despite the significant advances in the area of
cancer chemotherapy, radiotherapy, applied either
alone or as adjuvant, still remains a method of choice
for treatment of many malignant diseases. One of
them is prostate cancer, the most frequent cancer in
men population, which unfortunately shows a contin-
ual casualty increase (1).  The ultimate aim of radio-
therapy is to efficiently eradicate tumor cells with min-
imal deleterious effects to the surrounding normal tis-
sues and to the whole organism.  In that view, induc-
tion of apoptosis is very desirable therapeutic endpoint
(2, 3). However, much is yet to be learned about either
systemic or individual biological effects of both con-
ventional (gamma-, x-ray) or accelerated particle (pro-
ton, etc.) ionizing radiation in order to optimize clinical
results of treatment of human prostate cancer. 
Regardless of the routine use of simple test for
prostate specific antigen in sera, that can detect dis-
ease at an early stage (4, 5), the number of men with
metastatic prostate cancer is still high. The early sta-
ges of disease are usually managed by ionizing radia-
tion and/or hormone therapy, but there is no success-
ful therapy for metastatic prostate carcinoma. Advan-
ced disease is mostly treated by radiation therapy,
sometimes in combination with hormone or chemo-
therapy, but hormone withdrawal often leads to selec-
tion of hormone-independent clones (6). Dose-esca-
lated (i.e. 70–80 Gy) radiotherapy is an important
treatment option especially for men with intermediate-
risk prostate cancer (7). On the other hand, radiothe-
rapy is often inefficient due to radioresistance of pro-
state cancer cells.
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Recent studies suggest that some prostate can-
cer cells can undergo apoptosis (8). The response to
ionizing radiation, depends on a number of factors
such as the stage of differentiation, mutations in spe-
cific genes (such as p-53 and bcl-2) that will determine
the ability of the target cells to enter apoptosis (9, 10).
For clinical purposes (i.e. eradication of the tumor,
but prevention of undesired inflammatory sequelae,
radiation sickness and fibrosis), it is useful to investi-
gate whether the cells of certain types are susceptible
to apoptosis or necrosis, as well as to determine the
time and dose dependence of the process.  In addition
to cell killing, radiation can also lead to cell cycle arrest
and stopping of proliferation with significant decrease
in cell growth (11).
The purpose of this study is to investigate radia-
tion induced cell death in PC-3 prostate cancer cell line
in time- and dose-dependent manner. The changes in
cell growth following irradiation were also determined.
Materials and Methods
Cell lines. Human prostate cancer cell line PC-3
was purchased from American Type Culture Collec-
tion (CRL 1435, Rockville, MD). They are androgen
independent and were established from bone metas-
tasis, which is the most usual place for metastatic
prostate cancer. PC-3 were maintained in RPMI 1640
medium supplemented by 10% heat inactivated fetal
calf serum, 100 IU/mL penicillin/streptomycin and 2
mmol/L L-glutamine (Sigma Aldrich Chemie GmbH,
Germany), at 37 °C under 5% CO2 atmosphere.  Cells
were grown as monolayers in 75 cm2 culture bottles
supplied with 15 mL RPMI, and after a few passages
cells were transferred in 25 cm2 culture bottles (Nunk,
Nalgene, Danmark). 
Cell Irradiation. For investigation of radiation
induced effects on PC-3, 3×105 cells were seeded in
25 cm2 culture flasks, and after 72 hours were irradi-
ated at room temperature with 2, 10 or 20 Gy gamma-
rays from 60Co gamma-source, at the dose rate of 20
Gy/h. The effects of irradiation on cell viability, mor-
phology and genomic DNA structure were determined
24-, 48-, and 72 h after irradiation. 
Trypan blue exclusion assay. For analysis of
cell growth and spontaneous cell death in culture, cells
were seeded at a density of 12×103 cells/cm2 in 25
cm2 culture flasks.  Cell growth, viability and morpho-
logy were followed for 8 consecutive days, by trypan
blue exclusion (TBE) assay.  Medium from each  bot-
tle was collected, cells were harvested by trypsinization
(1 mL 0.25% / 0.02% trypsine/EDTA, Sigma Aldrich,
per bottle) and pooled with the medium. Cells were
washed twice in phosphate buffered saline (PBS) and
pelleted at 1800 rpm for 5 min at room temperature.
Pellets were resuspended in fresh media and the num-
ber of viable (trypan blue negative), dead (trypan blue
positive) and total cells (viable + dead) was counted in
five squares at 320× magnification using Neubauer
haemocytometer and Leitz-Wetzlar Orthoplan micro-
scope. Cell viability was determined as % of cells that
excluded trypan blue stain. The doubling time (td) was
calculated according to the following formula: 
td =
ln2
P
P = (ln x – ln x0) / t
where x represents cell number in time t, and x0
cell number in time t0.
The same assay was used for determination of
viable, dead and total cell number in irradiated sam-
ples 24-, 48- and 72 h post-irradiation. The viability
index (Vi) of each sample was calculated related to
appropriate, unirradiated control, which was used as
viability index 1 (100%).
Cell death analysis by flow cytometry. Double
staining of cells by Annexin and propidium iodide (PI)
enabled estimation of cell viability after irradiation and
discrimination between two ways of cell death – apop-
tosis and necrosis. After trypsinization and centrifuga-
tion of cells, approximately 105 cells of each sample
were mixed with 100 PL of Annexin V-FITC reagent
(Travigen Inc., Gaithersburg, MD, USA) containing
5 mg/mL Annexin V-FITC and 5 Pg/mL propidium
iodide, and incubated at room temperature for 15
minutes in dark and then diluted with 400 PL of bind-
ing buffer. Multiparameter measurement of the cell
sample in order to detect radiation-induced cell death
was performed using a FACS-calibur flow cytometer
(Becton Dickinson, San Jose, CA, USA) with 488 nm,
15 mW argon-ion laser. Staining of the cells with
Annexin V-FITC (Annexin) permitted identification of
cells in early apoptosis, while staining of the cells with
Annexin and PI permitted quantification of cells in the
late apoptosis and necrosis. Data were acquired imme-
diately after staining by analyzing about 20,000 cells/
sample. The data were further processed by Becton
Dickinson LYSIS II software.
DNA fragmentation assay. This assay was used
for confirmation of necrosis, detected by double stain-
ing and flow cytometryc analysis. It was performed as
previously described with minor modifications (12).
Cells were incubated in one volume of digestion buffer
(100 mmol/L NaCl, 25 mmol/L EDTA, 10 mmol/L
Tris-HCl, pH 8.0, 0.5% SDS and 0.5 mg/mL RNA-se
A) for 2 h at 50 °C, followed by the addition of pro-
teinase K (0.6 mg/mL) and digestion was continued
overnight. DNA was deproteinised using the phenol/
chloroform/isoamil-alcohol reagent, for three times.
The aqueous layer was transferred to a new tube and
precipitated with one volume of isopropanol and 1/10
volume of ammonium acetate overnight at 4 °C. The
DNA pellet was washed three times with ice-cold 95%
ethanol and dried at room temperature. The final DNA
pellet was resuspended in 20 mL TE buffer (10 mmol/L
Tris, pH 7.4, 1 mmol/L EDTA) and the concentration
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of DNA was determined spectrophotometrically.
Electrophoresis of 4’10 mg of each DNA sample, was
carried out for 60 min at 60 V at room temperature on
1% agarose gel containing 1 mg/mL ethidium bromi-
de. Gels were scanned by GelDoc apparatus.
Statistical analysis. For statistical analysis of
time- and dose- dependent changes in viability index
and flow-cytometric determination, two-way ANOVA
was used. If a statistical significance was found, Tukey
post-hoc test was used to determine which groups di-
ffer from each other. Statistical significance was
accepted if p<0.05.
Results
Analysis of cell growth and 
spontaneous cell death in culture
PC-3 cells were plated in 25 cm2 culture flasks,
at the density of 12 × 103 cells/cm2 (e.g. 3 × 105 cells
per bottle), and cell growth, viability and morphology
were monitored for 8 consecutive days (Figure 1).
During the first day post plating the viable cell number
increase from 12 × 103 cells/cm2 to almost 13.5 ×
103 cells/cm2, suggesting that plating efficiency was
very high. The log phase of cell growth occurred
between 2nd and 6th day post plating. The confluence
was reached on the 6th day at the cell density of about
116 × 103 cells/cm2. Further incubation led to the
slightly decrease in cell number. TBE assay showed
that approximately 2’8% of all cells were TB positive
at all time points, indicating that cell viability was high
during the whole experiment. We also calculated PC-3
cell doubling time, which was 32.9 ± 2.8 h under con-
ditions maintained in our laboratory.
Cell growth of irradiated PC-3 
human prostate cancer cells
Effects of gamma-ionizing radiation on PC-3
growth were evaluated by TBE assay. The test is con-
venient for determination of Viability (V) and Viability
index (Vi) after radiation treatment. TBE assay was
performed 24-, 48- and 72 h after irradiation by 2-,
10- and 20 Gy. The obtained results (Table I and
Figure 2) showed significant decrease in cell number
and Viability Index (Vi), comparing with appropriate
control, both by dose (F 190.1, p<0.001) and time (F
45.2, p<0.001) as determined by two-way ANOVA.
This effect was most pronounced 72 h after treatment
with 20 Gy, when the Vi decreased from 1, established
in control, to 0.35. The radiation dose which caused
decrease in cell Vi from 1 to 0.5, termed IC50 (mitotic
cell death dose), was 10.4 ± 0.4 Gy. The dose depen-
dent Vi (e.g. viable cell number) decrease was signifi-
cant for all experimental points (Table I). The statisti-
cal differences between groups were analyzed by
Tukey post hoc test, comparing irradiated samples
with the control from the same time point, and signi-
ficance was established at *p<0.05. The number of
TB positive cells, indicating cytotoxicity (actual cell
death), was relatively low (up to 20 %, data not shown),
which was in agreement with cytometric quantification
of necrotic cells determined after double Annexin V-
FITC/PI staining (Figure 3). 
Radiation-induced cell death 
analysis by flow cytometry
All samples analyzed by TBE, were also stained
by Annexin V-FITC and PI, and analyzed by FACS-
Calibur flow cytometer. The results of quantification of
cells in different states, such as viable cells, cells in
early apoptosis, cells in late apoptosis or necrotic cells,
and necrotic cells or cell aggregates, are presented in
Figure 3 A-D. Figure 3A represents a flow cytometry
scatter plot and the dots represent cells in different
Figure 1.   Growth and viability of PC-3 cells in culture
determined by TBE assay. Data are the mean SEM 
from 2 distinct experiments.
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Table I   Number of viable cells in the control and 60Co
gamma-irradiated human prostate cancer cells PC-3 
measured by TBE assay 24–72 h post-irradiation. 
Data are the mean ± SEM from 3 distinct experiments.
Statistical time- and dose-dependent differences were
determined by two way ANOVA and Tukey post hoc test.
** p<0.01, *** p<0.001.
Dose o
Time (h)
p
24
48
72
control 
(0 Gy)
57.3±1.6
92.4±4.9
84.6±3.9
2 Gy
** 
43.7±2.8
***
49.9±9.7
***
69.6±1.4
10 Gy
***
40.9±4.4
***
46.8±5.9
***
44.7±5.3
10 Gy
***
40.9±4.4
***
46.8±5.9
***
44.7±5.3
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states, depending on the place in scatter plot. Cells in
early apoptosis were Annexin positive, while PI staining
indicated late apoptosis or necrosis (Figure 3A). As it
may be observed from Figure 3B, cell viability of the
samples decreased with the increase in the radiation
dose and with the period of incubation. Radiation-
induced decrease of viability showed dose-dependent
significance which was judged by two-way ANOVA
analysis at p<0.05 (F 9.12, p<0.001), but not time-
dependent significance (F 2.06, p=0.142). The Tukey
post hoc test, used for comparison of irradiated sam-
ples with appropriate control, showed that only radia-
tion dose of 20 Gy induced significant viability decre-
ase, 48 and 72 h post irradiation. The evidence for
apoptosis was minimal in either control or irradiated
PC-3 cells. With the increase in the radiation dose, the
percentage of cells in the state of early apoptosis in-
creased from 0.2% up to 0.8 % (Figure 3C), but there
were neither time- nor dose-dependent significance (F
1.35, p=0.33 and F 1.42, p=0.33 respectively).
The radiation dose and time dependent increase
in number of PI positive cells in the late apoptosis or
necrosis was also observed. The dose dependent
increase in necrotic cells was significant (F 7.85,
p<0.001), but time-dependence was not statistically
significant (F 1.9, p=0.17). The Tukey post hoc analy-
sis showed significant increase in number of dead cells
after irradiation with 20 Gy, 48 and 72 h after treat-
ment (Figure 3D).
Electrophoretic analysis of purified 
genomic DNA from irradiated cells
The genomic DNA from control and irradiated
samples, including attached and floating cells, was
analyzed on 1% agarose gel containing 1 mg/mL ethi-
dium bromide. As it may be observed in Figure 4 the
initial fragmentation of PC-3 cell DNA to a high mole-
cular size band (>10 Kb) was visible in all samples. In
the case of irradiated samples, in addition to the frag-
mentation of PC-3 cell DNA to a high molecular size
band (>10 Kb), smaller fragments (1<Kb) also appe-
ared. The observed smear is most pronounced 72 h
post irradiation with doses of 10 and 20 Gy. It corre-
lated well with the highest percent of dead cells
obtained by cytometry (Figure 3D). DNA ladder was
not observed in examined samples, confirming flow
cytometric data, that PC-3 do not die by apoptosis
after gamma-irradiation.
Discussion
The hormone-independent metastatic prostate
cancer is incurable at present. In the lack of efficient
chemotherapeutic agents, ionizing radiation therapy
still remains as a method of choice for the disease cure.
It is known that apoptotic cell death plays an important
role in the death of both normal prostate and andro-
gen-dependent malignant prostate tissue following
androgen withdrawal. Cancer cell death is leading to a
decrease in either glandular or tumor volume, respec-
tively. However, recent data indicate that apoptosis
may not be the dominant form of cell death following
radio- and chemotherapy in epithelial tissues (7, 13).
Disruption of the pathways that lead to apoptosis is one
of the major mechanism by which cancer cells become
resistant to radiation or chemotherapy (14). 
In this paper, we have analyzed 60Co gamma-
radiation-induced death of PC-3 human prostate can-
cer cells. PC-3 cells originates from epithelial cells.
Figure 2.   Time course of viable cells number in the 
control and 60Co gamma-irradiated human prostate 
cancer cells PC-3 (A) and Viability index calculated 
according to the related control from the same time 
point (B) as measured in TBE assay. Error bars represent
standard error of the mean (SEM). Data are the mean 
SEM from 3 distinct experiments. 
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They are hormone-refractory cells derived from hu-
man bone metastasis of prostate adenocarcinoma,
representing advanced prostate cancer (15). For these
experiments, we chose doses of 2 and 10 Gy, to be
representative of the 1.8’2 Gy daily clinical fractions
given during curative radiotherapy and the 8’10 Gy
single doses given in palliative radiotherapy, as well as
the dose of 20 Gy which is in the range of cumulative
curative dose for prostate carcinomas (70’80 Gy). 
The growth curve of PC-3 cells showed sigmoid-
like shape, with the population doubling time about 33
h. The viability of PC-3 cells was 92’98 % throughout
the log phase of growth. The culture reach confluence
6th days post plating, at the density of 120 × 103
cells/cm2, which is considerable less than other epithe-
lial prostate cancer cell line, DU 145 (180 × 103
cells/cm2), suggesting that PC-3 are bigger than DU
145 (to be published). After day 6th, number of cells
slightly decreased, retaining surprisingly high viability
(97’98%). Based on data from cell growth curve, all
irradiation experiments were performed in the log
phase of cell growth. Cells were irradiated with 2’20
Gy from 60Co-source at the dose rate of 20 Gy/h. The
irradiated PC-3 cell cultures were followed for three
consecutive days i.e. through approximately two pro-
liferation cycles. The data obtained by the TBE assay,
showed significant decrease in cell Viability index, e.g.
in the number of viable cells in irradiated samples rel-
ative to the control from the same time point. The
process was dependent both on the radiation dose
and on the incubation time. On the other hand, the
number of TBE positive cells remained relatively low,
indicating that radiation caused cell cycle arrest and
blocking of cell proliferation, rather than actual cell
Figure 3.   Time course of percent changes in PC-3 cell viability and death after 60Co gamma-irradiation as determined 
by flow cytometry. Viable cells (A), early apoptosis (B) or late apoptotic/necrotic cells (C). Data are the mean (n=3) and the
error bars represent SEM. Statistical differences were determined by two-way ANOVA followed by Tukey post hoc analysis. 
** p<0.01, *** p<0.001.
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death. The obtained data enabled determination of
doses which induced 50% of cell growth inhibition
(named IC50) and 50% of cytotoxicity, i.e. dose which
induced 50% of trypan blue positive cells (EC50). IC50
was achieved at the dose of 10.4 Gy, but EC50 was
higher than applied doses, as 20 Gy induced only 20%
of trypan blue positive cells. This indicated that the
radiation treatment in the clinically relevant dose inter-
val would predominantly inhibit PC-3 growth rather
than induce cell killing. The similar results were obtai-
ned for other hormone-refractory epithelial prostate
cancer cell line DU 145, derived from brain metastasis
(to be published), but in the case of cervix epithelial
cancer cells HeLa S3, the same doses of ionizing radi-
ation induced cell death in up to 45% of irradiated cells
(16). This comparison suggests that prostate cancer
cells are much radioresistant than HeLa S3 cell line.
In order to determine the form of radiation-indu-
ced PC-3 cell death two different techniques were used:
flow-cytometry analysis of cell morphological features
after double staining with propidium iodide and Anne-
xin-V-FITC, and DNA electrophoresis of purified DNA.
Simultaneous staining of cells with Annexin V-FITC
and propidium iodide enabled distinction of early apo-
ptosis from late apoptosis and/or necrosis. After dou-
ble staining and flow-cytometryc analysis of control
and irradiated samples, the most of dead cells were in
late apoptosis or necrosis (Annexin V+, PI+ cells). The
early apoptosis (Annexin V+, PI- cells) occurred in
insignificant number of cells, less than 1% of total cell
number in each sample, and there were no significant
changes in percent of apoptotic cells depending on
time or dose. On the contrary, the cell necrosis was do-
se dependent, as determined by two-way ANOVA, and
was most pronounced 72 hours post treatment. These
results suggest that the prevailing form of 60Co gamma
radiation-induced PC-3 cell death was necrosis.
As it was not possible to distinguish the necrosis
from the late apoptosis by double staining, it was nec-
essary to perform the gel electrophoresis of purified
genomic DNA from PC-3 cells. DNA fragmentation
assay confirmed the presence of the necrosis process,
showing the absence of DNA ladder characteristic for
apoptosis in control (17), as well as in irradiated sam-
ples. One explanation for the absence of apoptosis fol-
lowing radiotherapy in PC-3 cell line is that these cells
have mutant p53 gene. However, the impairment of
other mechanisms necessary for initiation of the apop-
totic process is not excluded. Namely, recent investi-
gation showed that gamma-radiation activates acidic
sphingomyelinase to produce ceramide, a catabolic
product of membrane sphingolipids that is a cell death
signal (14, 18, 19). It was suggested that the other
epithelial prostate carcinoma LNCaP cells are highly
resistant to induction of apoptosis by gamma-radia-
tion due to a defect in ceramide generation (14, 20,
21). Likewise, resistance to apoptosis involves a defect
in ceramide generation in the PC-3 prostate cancer
cell line (20, 22). 
In summary, the obtained results suggests that
60Co gamma-ionizing radiation caused notable human
prostate cancer PC-3 cell killing. The irradiated PC-3
cells were mostly dying by necrosis, while apoptotic
cell death was negligible. Although within the radiation
doses used in this study (2’20 Gy) the EC50 i.e. 50%
of cytotoxicity was not achieved, we found significant
cell growth inhibition with IC50 of 10.4 Gy. Thus, this
in vitro study suggests, that the increase in radiation
dose may have an important cytostatic effect, rather
than eradicating the advanced prostatic carcinoma. It
also suggests that, in addition to gamma irradiation,
current antitumor strategies should introduce novel
cytotoxic adjuvant or radiosensitizers, in order to achi-
eve complete eradication of metastatic human pro-
state cancer.
Acknowledgment. This study was supported by
the Ministry for Science, Technology and Development
of Serbia, grant No. BOI-1953
348 Jugoslov Med Biohem 2004; 23 (4)
Figure 4.   Agarose gel electrophoresis of genomic DNA
extracted from 60Co gamma-irradiated PC-3 cells. Lane S:
DNA standard molecular size markers; lanes 1–12: 
genomic DNA pattern of samples irradiated with 0, 2-, 
10 and 20 Gy respectively, isolated 24 hours (lines 1–4),
48 h (lines 5–8) or 72 h (lines 9–12) post-irradiation.
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]ELIJSKA SMRT U OZRA^ENIM ]ELIJAMA KANCERA PROSTATE 
ANALIZIRANA PROTO^NOM CITOMETRIJOM
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3Laboratorija za molekularnu neurobiologiju, Institut za biolo{ka istra`ivanja, Beograd 
Kratak sadr`aj: Uprkos zna~ajnom napretku u hemoterapiji kancera, radioterapija ostaje metod izbora u
tretmanu metastaziranog kancera prostate. Ovaj rad predstavlja kvantitativnu analizu efekata 60Co gama zra~enja
na }elijski rasti i }elijsku smrt PC-3 }elijske linije humanog kancera prostate, pri ~emu je pra}ena vremenska
(2–72h) i dozna zavisnost (2–20 Gy).  Ozra~ene PC-3 }elije su uglavnom umirale nekrozom u kasnijem vremen-
skom intervalu (72h), dok je apoptoza bila zanemarljiva. Vrednost EC50 odnosno 50% citotoksi~nosti  nije dosti-
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